USD 0.05
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.53 Million CAD | -1.2% |
2022 | 2.56 Million CAD | 12.61% |
2021 | 2.28 Million CAD | 418.39% |
2020 | 440.09 Thousand CAD | 111.18% |
2019 | 208.39 Thousand CAD | -82.64% |
2018 | 1.2 Million CAD | -58.62% |
2017 | 2.9 Million CAD | 27.46% |
2016 | 2.27 Million CAD | -35.74% |
2015 | 3.54 Million CAD | 331.56% |
2014 | 820.41 Thousand CAD | 2.43% |
2013 | 800.99 Thousand CAD | 3955.45% |
2012 | 19.75 Thousand CAD | -89.63% |
2011 | 190.49 Thousand CAD | -85.92% |
2010 | 1.35 Million CAD | -24.07% |
2009 | 1.78 Million CAD | -29.67% |
2008 | 2.53 Million CAD | 196.66% |
2007 | 854.16 Thousand CAD | 293.86% |
2006 | 216.87 Thousand CAD | -27.92% |
2005 | 300.89 Thousand CAD | -63.78% |
2004 | 830.76 Thousand CAD | 189.93% |
2003 | 286.54 Thousand CAD | 50.99% |
2002 | 189.77 Thousand CAD | 125.97% |
2001 | 83.98 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 2.61 Million CAD | -6.42% |
2024 Q1 | 2.79 Million CAD | 10.24% |
2023 Q2 | 2.14 Million CAD | -6.65% |
2023 FY | 2.53 Million CAD | -1.2% |
2023 Q4 | 2.53 Million CAD | 3.47% |
2023 Q3 | 2.45 Million CAD | 14.43% |
2023 Q1 | 2.29 Million CAD | -10.6% |
2022 Q2 | 1.98 Million CAD | -6.49% |
2022 FY | 2.56 Million CAD | 12.61% |
2022 Q4 | 2.56 Million CAD | 20.72% |
2022 Q3 | 2.12 Million CAD | 7.2% |
2022 Q1 | 2.12 Million CAD | -6.95% |
2021 Q2 | 2.54 Million CAD | -7.26% |
2021 Q1 | 2.74 Million CAD | 522.61% |
2021 Q3 | 2.51 Million CAD | -0.93% |
2021 FY | 2.28 Million CAD | 418.39% |
2021 Q4 | 2.28 Million CAD | -9.38% |
2020 Q1 | 607.06 Thousand CAD | 191.3% |
2020 Q2 | 532.08 Thousand CAD | -12.35% |
2020 FY | 440.09 Thousand CAD | 111.18% |
2020 Q3 | 355.8 Thousand CAD | -33.13% |
2020 Q4 | 440.09 Thousand CAD | 23.69% |
2019 Q1 | 970.18 Thousand CAD | -19.16% |
2019 Q2 | 649.3 Thousand CAD | -33.07% |
2019 Q3 | 410.95 Thousand CAD | -36.71% |
2019 Q4 | 208.39 Thousand CAD | -49.29% |
2019 FY | 208.39 Thousand CAD | -82.64% |
2018 Q4 | 1.2 Million CAD | -57.36% |
2018 Q3 | 2.81 Million CAD | -2.36% |
2018 Q2 | 2.88 Million CAD | 16.88% |
2018 Q1 | 2.46 Million CAD | -14.95% |
2018 FY | 1.2 Million CAD | -58.62% |
2017 Q4 | 2.9 Million CAD | 104.36% |
2017 FY | 2.9 Million CAD | 27.46% |
2017 Q3 | 1.41 Million CAD | -35.68% |
2017 Q2 | 2.2 Million CAD | 33.42% |
2017 Q1 | 1.65 Million CAD | -27.32% |
2016 FY | 2.27 Million CAD | -35.74% |
2016 Q3 | 3.2 Million CAD | -5.18% |
2016 Q2 | 3.38 Million CAD | -8.99% |
2016 Q1 | 3.71 Million CAD | 6.4% |
2016 Q4 | 2.27 Million CAD | -29.06% |
2015 Q4 | 3.49 Million CAD | 6.44% |
2015 Q3 | 3.28 Million CAD | -7.31% |
2015 Q1 | 3.51 Million CAD | 137.59% |
2015 Q2 | 3.54 Million CAD | 0.72% |
2015 FY | 3.54 Million CAD | 331.56% |
2014 Q2 | 820.41 Thousand CAD | -7.62% |
2014 Q4 | 1.47 Million CAD | 140.87% |
2014 Q1 | 888.04 Thousand CAD | 7.49% |
2014 FY | 820.41 Thousand CAD | 2.43% |
2014 Q3 | 614.26 Thousand CAD | -25.13% |
2013 FY | 800.99 Thousand CAD | 3955.45% |
2013 Q4 | 826.17 Thousand CAD | -13.45% |
2013 Q3 | 954.53 Thousand CAD | 19.17% |
2013 Q2 | 800.99 Thousand CAD | 126.0% |
2013 Q1 | 354.42 Thousand CAD | -3.06% |
2012 Q3 | 362.16 Thousand CAD | 1733.67% |
2012 Q1 | 75.99 Thousand CAD | -26.16% |
2012 Q2 | 19.75 Thousand CAD | -74.01% |
2012 Q4 | 365.61 Thousand CAD | 0.95% |
2012 FY | 19.75 Thousand CAD | -89.63% |
2011 FY | 190.49 Thousand CAD | -85.92% |
2011 Q4 | 102.91 Thousand CAD | -24.23% |
2011 Q3 | 135.82 Thousand CAD | -28.7% |
2011 Q1 | 987.75 Thousand CAD | -1.82% |
2011 Q2 | 190.49 Thousand CAD | -80.71% |
2010 Q3 | 1.24 Million CAD | -8.25% |
2010 Q4 | 1 Million CAD | -18.96% |
2010 Q1 | 1.46 Million CAD | -55.14% |
2010 FY | 1.35 Million CAD | -24.07% |
2010 Q2 | 1.35 Million CAD | -7.5% |
2009 Q1 | 1.94 Million CAD | -9.68% |
2009 FY | 1.78 Million CAD | -29.67% |
2009 Q2 | 1.78 Million CAD | -8.39% |
2009 Q4 | 3.26 Million CAD | 0.0% |
2008 Q4 | 2.15 Million CAD | -8.05% |
2008 Q1 | 2.69 Million CAD | 38.54% |
2008 Q3 | 2.34 Million CAD | -7.56% |
2008 FY | 2.53 Million CAD | 196.66% |
2008 Q2 | 2.53 Million CAD | -6.01% |
2007 Q4 | 1.94 Million CAD | 54.98% |
2007 Q1 | 176.31 Thousand CAD | 0.33% |
2007 Q2 | 854.16 Thousand CAD | 384.45% |
2007 Q3 | 1.25 Million CAD | 47.01% |
2007 FY | 854.16 Thousand CAD | 293.86% |
2006 Q3 | 208.32 Thousand CAD | -3.94% |
2006 Q4 | 175.74 Thousand CAD | -15.64% |
2006 Q2 | 216.87 Thousand CAD | 4.37% |
2006 Q1 | 207.8 Thousand CAD | -33.44% |
2006 FY | 216.87 Thousand CAD | -27.92% |
2005 Q2 | 300.89 Thousand CAD | -55.68% |
2005 Q3 | 237.14 Thousand CAD | -21.19% |
2005 FY | 300.89 Thousand CAD | -63.78% |
2005 Q4 | 312.19 Thousand CAD | 31.65% |
2005 Q1 | 678.88 Thousand CAD | 20.05% |
2004 Q1 | 1.2 Million CAD | -12.85% |
2004 FY | 830.76 Thousand CAD | 189.93% |
2004 Q3 | 687.82 Thousand CAD | -17.21% |
2004 Q4 | 565.52 Thousand CAD | -17.78% |
2004 Q2 | 830.76 Thousand CAD | -30.92% |
2003 Q3 | 427.71 Thousand CAD | 49.27% |
2003 Q2 | 286.54 Thousand CAD | 76.88% |
2003 FY | 286.54 Thousand CAD | 50.99% |
2003 Q4 | 1.37 Million CAD | 222.63% |
2003 Q1 | 162 Thousand CAD | 0.77% |
2002 FY | 189.77 Thousand CAD | 125.97% |
2002 Q3 | 179.75 Thousand CAD | 0.0% |
2002 Q4 | 160.76 Thousand CAD | -10.56% |
2001 FY | 83.98 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Bio Medica Corporation | 1.26 Million USD | -100.016% |
Arrayit Corporation | 1 Million USD | -153.722% |
Atlantic International Corp. | 4.43 Million USD | 42.786% |
Biocept, Inc. | 30.87 Million USD | 91.779% |
Bioqual, Inc. | 56.58 Million USD | 95.515% |
CardioGenics Holdings Inc | 231.93 Thousand USD | -994.375% |
DermTech, Inc. | 121.93 Million USD | 97.918% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.939% |
HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 85.722% |
iMD Companies, Inc. | 190.13 Thousand USD | -1234.935% |
IDenta Corp. | 1.52 Million USD | -65.974% |
Interpace Biosciences, Inc. | 13.02 Million USD | 80.507% |
Integrative Health Technologies, Inc. | 8.25 Million USD | 69.241% |
InVitro International | 1.53 Million USD | -65.462% |
Lumos Diagnostics Holdings Limited | 26.83 Million USD | 90.542% |
Many Bright Ideas Technologies Inc. | 2312.00 USD | -109683.953% |
Medical Imaging Corp. | 4.19 Million USD | 39.446% |
NovelStem International Corp. | 2.25 Million USD | -12.582% |
Optigenex Inc. | 1.88 Million USD | -34.418% |
PharmChem, Inc. | 2.76 Million USD | 8.221% |
Proteome Sciences plc | 14.58 Million USD | 82.598% |
Response Genetics, Inc | 48.88 Million USD | 94.808% |
Rennova Health, Inc. | 20.57 Million USD | 87.662% |
RushNet, Inc. | 6.04 Million USD | 58.03% |
ScreenPro Security Inc. | 1.26 Million USD | -101.228% |
Stella Diagnostics Inc. | 472.42 Thousand USD | -437.274% |
StageZero Life Sciences Ltd. | 700.65 Thousand USD | -262.263% |
Todos Medical Ltd. | 15.26 Million USD | 83.375% |